MB Hultin

von Willebrand disease (VWD): evidence‐based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) ¹

William L. Nichols, MB Hultin, Allison James et al. · Haemophilia · 2008 · 958 citations

Medicine, Hematology, Pathology +17

Pleiotropic effects of antithrombin strand 1C substitution mutations.

David A. Lane, R.J. Olds, J. Conard et al. · Journal of Clinical Investigation · 1992 · 95 citations · Full text

Medicine, Molecular Biology, Molecular Genetics +16

Evaluation of the safety, recovery, half-life, and clinical efficacy of antithrombin III (human) in patients with hereditary antithrombin III deficiency. Cooperative Study Group [see comments]

D Ménaché, J. P. O'Malley, JB Schorr et al. · Blood · 1990 · 92 citations · Full text

Medicine, Hematology, Pharmacokinetics +12

Activation of factor X by factors IXa and VIII; a specific assay for factor IXa in the presence of thrombin-activated factor VIII

MB Hultin, Yale Nemerson · Blood · 1978 · 88 citations · Full text

Medicine, Hematology, Pathology +15

Normal pregnancy in a patient with a prior postpartum factor VIII inhibitor: with observations on pathogenesis and prognosis

BS Coller, MB Hultin, LW Hoyer et al. · Blood · 1981 · 85 citations · Full text

Medicine, Gynecology, Obstetrics +14